Injection

The United States remains tightly in the grasp of an ongoing, and escalating, crisis of deaths caused by opioid overdoses. With a record-high 109,000 people dying in 2022, it is clear…

TORONTO, 25 sept. 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ : RARE), compagnie biopharmaceutique spécialisée dans le développement et la commercialisation de…

SYFOVRE reduced nonsubfoveal GA lesion growth by up to 45% between Months 24-30 compared to projected sham in the GALE long-term extension study Safety profile of SYFOVRE in GALE was…

BRISBANE, Australia – When given a choice for pre-exposure prophylaxis (PrEP) to prevent infection with HIV, women…

PARIS et CAMBRIDGE, Mass., 19 juill. 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO — NASDAQ : NBTX – la « Société »), société de biotechnologie en phase de développement clinique…

BATON ROUGE, La., July 17, 2023 (GLOBE NEWSWIRE) -- A new means of wound-healing technology could be available to surgeons and patients in the near future thanks to a team of researchers…

First-and-only approved FcRn antagonist for gMG patients by NMPA 68% of anti-AChR antibody positive gMG patients treated with VYVGART were responders (n=44/65) on the Myasthenia Gravis…

Newark, New Castle, USA, June 27, 2023 (GLOBE NEWSWIRE) -- The global injection pen market analysis was conducted by Growth Plus Reports in 2022 and is valued at US$ 40.24 billion. The…

New York, June 20, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of subcutaneous (SC) Vyvgart Hytrulo…

Wilmington, Delaware, United States, June 17, 2023 (GLOBE NEWSWIRE) -- The global paclitaxel injection market stood at US$ 811.0 million in 2022, and the global market is projected to…